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Propantheline bromide (PB), used as an
ulcer medication in humans, was tested for
its effects on reproduction and fertility in
Swiss CD-1 mice using the RACB proto-
col (Morrissey et al., Fundam Appl Toxicol
13:747-777 [1989]). Data on food and
water consumption, body weights, and
clinical signs during a 2-week dose-range-
finding study (Task 1) were used to set
exposure concentrations for the Task 2
continuous cohabitation study at 0.0, 0.05,
0.16, and 0.5% in feed. Based on mean
body weight and average feed consumption
data, the estimated daily doses were 71,
235, and 760 mg/kg bodyweight.
In the Fo animals, there were no deaths
during Task 2. Body weight gain for the
top dose males was reduced by a factor of4
compared to controls. There was a statisti-
cally significant, but small (6%), reduction
in the number oflitters per pair at the top
dose. The only other changes in reproduc-
tive indices for the Fo pairs occurred at the
high dose level and were a reduction in the
mean weight of F1 pups adjusted for litter
size at the top dose by 4% and an increase
in the length of time to deliver each litter.
This delay was greatest for the first three
litters, while the difference was less for the
last two litters.
These modest reproductive effects (6%
decrease in litters per pair, and 4% decrease
in adjusted live pup weight) were consid-
ered too small to be detectable in the single
litter generated by the Task 3 crossover, so
Task 3 was not conducted.
There were no adverse effects of PB
consumption on the growth or viability of
the F1 offspring in the last litter that was
reared for second-generation testing. After
weaning the F2 mice, the F1 mice from
control, middle and high dose groups were
killed and necropsied. There were no
weight changes or gross lesions noted in
females, while male body weights were
reduced by 11% at the top dose. There
were no changes in sperm indices or in
estrous cycle parameters.
Only mice from the control and high
dose groups were kept and treated with PB
from weaning to the mating trial at postna-
tal day 74 ± 10. Compared to controls, the
high dose PB mice had similar-size litters,
with the same proportion oflive pups and
same sex ratio, but the adjusted live pup
weight was reduced by 11%.
After the delivery and evaluation ofthe
F2 litters and estrous cycle data collection,
the Fl adults were killed and necropsied.
There was an 8% reduction in female body
weight and no change in organ weights.
For males, body weight was reduced by
10%, and prostate weight was reduced by
25%. Epididymal sperm density was
reduced at the high dose by 15%, while
estrous cycle length and characteristics
were unchanged.
Thus, propantheline bromide caused
detectable but small reductions in litter
number, in both generations reduced
adjusted pup weight, and reduced F1
prostate weight and sperm count. These
effects were seen concomitant with male
body weight changes but no other signifi-
cant nonreproductive toxicities.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: PB86160330/AS
Chemical: Propantheline Bromide
CAS#: 50-34-0
Mode of exposure: Feed
Species/strain: Swiss CD-1 mice
Fo generation Dose concentration -4 0.05% 0.16%
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Bodyweight ,
Kidneyweight8 ., |l
Liverweighta . * -
Mortality . , _
Feed consumption .- , _, _
Waterconsumption _
Clinical signs
x litters/pair - - I
#livepups/litter; pupwt./litter - - - -
Cumulative days to litter _
Absolute testis, epididymisweighta . * -
Sexaccessoryglandweight8(prostate,seminal vesicle) . -
Epidid. sperm parameters (#, motility, morphology) .
Estrous cycle length
[Determination ofaffected sex(crossover) Male Female Both
Dose level * 0__._ _
F, generation Dose concentration-| 0.05% 0.169 0 l
Pupgrowth to weaning _ ,
Mortality -.- _ _
Adult bodyweight - . 4,4
Kidneyweighta . -
Liverweighta .
Feedconsumption .
Waterconsumption . *
Clinical signs _ -
Fertility index . .
#livepups/litter; pupwt./litter 1 . .4
Absolutetestis, epididymisweighta j J *
Sexaccessoryglandweighta(prostate, seminal vesicle) . 4 -
Epidid. sperm parameters(#,motility, morphology) I . I 1
Estrouscycle length J*
Affected sex? Unclear
Studyconfounders: None
F1 more sensitivethan F0? No
Postnataltoxicity: No
Legend: -, no change; *, no observation; 1 or 4, statistically significant change (p<0.05); , no change in males orfemales. "Adjusted for body weight.
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